Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The restricted neutralization breadth of vaccine-elicited antibodies is a major limitation of current human immunodeficiency virus-1 (HIV-1) candidate vaccines. In order to permit the efficient identification of vaccines with enhanced capacity for eliciting cross-reactive neutralizing antibodies (NAbs) and to assess the overall breadth and potency of vaccine-elicited NAb reactivity, we assembled a panel of 109 molecularly cloned HIV-1 Env pseudoviruses representing a broad range of genetic and geographic diversity. Viral isolates from all major circulating genetic subtypes were included, as were viruses derived shortly after transmission and during the early and chronic stages of infection. We assembled a panel of genetically diverse HIV-1-positive (HIV-1 + ) plasma pools to assess the neutralization sensitivities of the entire virus panel. When the viruses were rank ordered according to the average sensitivity to neutralization by the HIV-1 + plasmas, a continuum of average sensitivity was observed. Clustering analysis of the patterns of sensitivity defined four subgroups of viruses: those having very high (tier 1A), above-average (tier 1B), moderate (tier 2), or low (tier 3) sensitivity to antibody-mediated neutralization. We also investigated potential associations between characteristics of the viral isolates (clade, stage of infection, and source of virus) and sensitivity to NAb. In particular, higher levels of NAb activity were observed when the virus and plasma pool were matched in clade. These data provide the first systematic assessment of the overall neutralization sensitivities of a genetically and geographically diverse panel of circulating HIV-1 strains. These reference viruses can facilitate the systematic characterization of NAb responses elicited by candidate vaccine immunogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Estimating the Number of Clusters in a Data Set Via the Gap Statistic
Tibshirani, R., Walther, G., & Hastie, T. (2001) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00293 · Cited by 6,205
A dendrite method for cluster analysis
Caliński, T., & Harabasz, J. (1974) · Communications in Statistics · doi:10.1080/03610927408827101 · Cited by 4,480
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
Self-citationFiebig, E. W., Wright, D. J., Rawal, B. D., Garrett, P. E., Schumacher, R. T., Peddada, L., Heldebrant, C., Smith, R., Conrad, A., Kleinman, S. H., et al. (2003) · AIDS · doi:10.1097/00002030-200309050-00005 · Cited by 1,305
Mascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L., et al. (2000) · Nature Medicine · doi:10.1038/72318 · Cited by 1,250
Self-citationPlatt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., & Kabat, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2855-2864.1998 · Cited by 1,219
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Self-citationKwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Baba, T. W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W., Ayehunie, S., Cavacini, L. A., Posner, M. R., Katinger, H., Stiegler, G., et al. (2000) · Nature Medicine · doi:10.1038/72309 · Cited by 849
Mascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4009-4018.1999 · Cited by 783
Self-citationHIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Wu, X., O'Brien, W. A., Ratner, L., Kappes, J. C., Shaw, G. M., & Hunter, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8358-8367.2000 · Cited by 742
Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
Self-citationParren, P. W. H. I., Marx, P. A., Hessell, A. J., Luckay, A., Harouse, J., Cheng-Mayer, C., Moore, J. P., & Burton, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8340-8347.2001 · Cited by 662
Shaw, G. M., Hahn, B. H., Arya, S. K., Groopman, J. E., Gallo, R. C., & Wong-Staal, F. (1984) · Science · doi:10.1126/science.6095449 · Cited by 633
Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays
Montefiori, D. C. (2004) · Current Protocols in Immunology · doi:10.1002/0471142735.im1211s64 · Cited by 580
Self-citationRole of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6489-6495.1992 · Cited by 446
GP120: Target for Neutralizing HIV-1 Antibodies
Pantophlet, R., & Burton, D. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090557 · Cited by 445
Mascola, J. R., Snyder, S. W., Weislow, O. S., Belay, S. M., Belshe, R. B., Schwartz, D. H., Clements, M. L., Dolin, R., Graham, B. S., Gorse, G. J., et al. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.2.340 · Cited by 436
Self-citationBroad HIV-1 neutralization mediated by CD4-binding site antibodies
Li, Y., Migueles, S. A., Welcher, B., Svehla, K., Phogat, A., Louder, M. K., Wu, X., Shaw, G. M., Connors, M., Wyatt, R. T., et al. (2007) · Nature Medicine · doi:10.1038/nm1624 · Cited by 383
Self-citationChallenges in the development of an HIV-1 vaccine
Barouch, D. H. (2008) · Nature · doi:10.1038/nature07352 · Cited by 380
Li, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., Morris, L., Williamson, C., Robinson, J. E., Decker, J. M., Li, Y., Salazar, M. G., Polonis, V. R., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01730-06 · Cited by 359
Self-citationBinley, J. M., Lybarger, E. A., Crooks, E. T., Seaman, M. S., Gray, E., Davis, K. L., Decker, J. M., Wycuff, D., Harris, L., Hawkins, N., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01762-08 · Cited by 355
Self-citationWalker, B. D., & Burton, D. R. (2008) · Science · doi:10.1126/science.1152622 · Cited by 338
Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations
Bhattacharya, T., Daniels, M., Heckerman, D., Foley, B., Frahm, N., Kadie, C., Carlson, J., Yusim, K., McMahon, B., Gaschen, B., et al. (2007) · Science · doi:10.1126/science.1131528 · Cited by 242
Self-citationConley, A. J., Gorny, M. K., Kessler, J. A., Boots, L. J., Ossorio-Castro, M., Koenig, S., Lineberger, D. W., Emini, E. A., Williams, C., & Zolla-Pazner, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.6994-7000.1994 · Cited by 211
Montefiori, D. C., Robinson, W. E., Schuffman, S. S., & Mitchell, W. M. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.2.231-235.1988 · Cited by 201
Self-citationHIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.
Jp, M., & Ho, D. D. (1995) · PubMed · Cited by 189
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
Haynes, B. F., & Montefiori, D. C. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.3.347 · Cited by 155
Self-citationBures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., Caudrelier, P., Habib, R. E., Klein, M. C. A., Lazzarin, A., et al. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200750054756 · Cited by 147
Self-citationBrown, B. K., Darden, J. M., Tovanabutra, S., Oblander, T., Frost, J. D., Sanders‐Buell, E., de Souza, M. S., Birx, D. L., McCutchan, F. E., & Polonis, V. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6089-6101.2005 · Cited by 128
Self-citationPolonis, V. R., Brown, B. K., Borges, A. R., Zolla‐Pazner, S., Dimitrov, D. S., Zhang, M.-Y., Barnett, S. W., Ruprecht, R. M., Scarlatti, G., Fenyö, E.-M., et al. (2008) · Virology · doi:10.1016/j.virol.2008.02.007 · Cited by 121
Self-citationKulkarni, S., Lapedes, A. S., Tang, H., Gnanakaran, S., Daniels, M., Zhang, M., Tanmoy Bhattacharya, A., Li, M., Polonis, V. R., McCutchan, F. E., et al. (2009) · Virology · doi:10.1016/j.virol.2008.12.032 · Cited by 105
Self-citationAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
Haynes, B. F., & Montefiori, D. C. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.4.579 · Cited by 94
Self-citationPoss, M. L., & Overbaugh, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5255-5264.1999 · Cited by 81
Shu, Y., Winfrey, S., Yang, Z., Xu, L., Rao, S. S., Srivastava, I. K., Barnett, S. W., Nabel, G. J., & Mascola, J. R. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.046 · Cited by 76
Self-citationWu, X., Sambor, A., Nason, M., Yang, Z., Wu, L., Zolla‐Pazner, S., Nabel, G. J., & Mascola, J. R. (2008) · Virology · doi:10.1016/j.virol.2008.07.007 · Cited by 36
Self-citation
Cited by
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Self-citationSequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y. K., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011) · Science · doi:10.1126/science.1207227 · Cited by 1,139
Self-citationCo-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Liao, H.-X., Lynch, R., Zhou, T., Gao, F., Alam, S. M., Boyd, S. D., Fire, A. Z., Roskin, K. M., Schramm, C. A., Zhang, Z., et al. (2013) · Nature · doi:10.1038/nature12053 · Cited by 988
Self-citationFocused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Wu, X., Zhou, T., Zhu, J., Zhang, B., Georgiev, I., Wang, C., Chen, X., Longo, N. S., Louder, M., McKee, K., et al. (2011) · Science · doi:10.1126/science.1207532 · Cited by 784
Self-citationEfficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Hammer, S. M., Sobieszczyk, M. E., Janes, H., Karuna, S. T., Mulligan, M. J., Grove, D., Koblin, B. A., Buchbinder, S. P., Keefer, M. C., Tomaras, G. D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310566 · Cited by 598
Self-citation
Metadata
- Authors
- Seaman, M. S., Janes, H., Hawkins, N., Grandpre, L. E., Devoy, C., Giri, A., Coffey, R. T., Harris, L., Wood, B., Daniels, M. G., Bhattacharya, T., Lapedes, A., Polonis, V. R., McCutchan, F. E., Gilbert, P. B., Self, S. G., Korber, B. T., Montefiori, D. C., & Mascola, J. R.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2010-02
- Volume
- 84
- Issue
- 3
- Pages
- 1439-1452
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2122210861
- Cited by
- 632
- References
- 41
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.